Showing results (61-70 of 164) with videos related to
Sort By:
Pageof 17
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 25, 2006
How are quality of life ratings made? Toward a model of quality of life in people with dementiaL M T Byrne-Davis, P D Bennett, G K WilcockCurrent Alzheimer Research|May 27, 2017
Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease PatientsEmma J Wams, Gordon K Wilcock, Russell G Foster, et al.Brain : a Journal of Neurology|July 19, 2001
Attentional control in Alzheimer's diseaseA D Baddeley, H A Baddeley, R S Bucks, et al.Clinical Pharmacology and Therapeutics|June 1, 1993
Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's diseaseJ M Ford, C A Truman, G K Wilcock, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 25, 2013
Role of depression in predicting time to conversion to mild cognitive impairmentKatherine Dean, Abderrahim Oulhaj, Giovanna Zamboni, et al.Dementia and Geriatric Cognitive Disorders|November 29, 2002
Patterns of clinically detectable treatment effects with galantamine: a qualitative analysisChristine Joffres, Romola S Bucks, Judy Haworth, et al.Neuroreport|May 11, 2002
Age-related changes in the preattentional detection of visual changeA Tales, T Troscianko, G K Wilcock, et al.Journal of the Neurological Sciences|December 1, 1982
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalitiesG K Wilcock, M M Esiri, D M Bowen, et al.Experimental Gerontology|February 3, 2007
Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's diseaseDoris Culpan, Abigail Cornish, Seth Love, et al.Age and Ageing|July 1, 1989
Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot studyD R Forsyth, D J Surmon, R A Morgan, et al.Pageof 17